Literature DB >> 23224647

What distinguishes highly pathogenic staphylococci from medium- and non-pathogenic?

Ralf Rosenstein1, Friedrich Götz.   

Abstract

Members of the genus Staphylococcus are widespread as commensals of humans and animals where they colonize the skin or mucous membranes. While this coexistence remains mostly untroubled, especially for the healthy host, the bacteria may pose a serious threat for the human or animal host when they get access to inner layers of the body through breaches in skin or membranes. Among the members of the genus a wide span exists in the ability to cope with the hostile conditions encountered in the bloodstream of the living host as a scarce supply of certain nutrients, attacks of the immune system, or anti-infective measures undertaken in the clinical field. In this respect, Staphylococcus aureus is by far the most versatile species of the genus. Its equipment with a huge repertoire of different virulence factors and additional supportive gene products that increase the capability to survive within the living host makes S. aureus the leading pathogen not only within the genus but also one of the most threatening microorganisms regarding hospitally and community-acquired infections. Compared with S. aureus, the other virulent species of the genus like S. epidermidis, S. lugdunensis, S. saprophyticus, and S. haemolyticus have a more limited arsenal of virulence factors resulting in a specialized spectrum of diseases and a generally lower degree of pathogenicity. Besides the highly and medium-pathogenic staphylococci, the genus comprises also species like S. carnosus, S. xylosus, and S. equorum that are generally inconspicuous regarding clinical occurrences. Some strains of this group are used in the food industry and can be graded as non-pathogenic. This review aims to work out the differences between the pathogenic properties of highly and medium-pathogenic staphylococcal species and to draw a comparison between the pathogenic species and the food-grade S. carnosus TM300.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23224647     DOI: 10.1007/82_2012_286

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  23 in total

1.  Acquisition of the Phosphate Transporter NptA Enhances Staphylococcus aureus Pathogenesis by Improving Phosphate Uptake in Divergent Environments.

Authors:  Jessica L Kelliher; Jana N Radin; Kyle P Grim; Paola K Párraga Solórzano; Patrick H Degnan; Thomas E Kehl-Fie
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

2.  Preventing Implant-Associated Infections by Silver Coating.

Authors:  Richard Kuehl; Priscilla S Brunetto; Anne-Kathrin Woischnig; Massimo Varisco; Zarko Rajacic; Juerg Vosbeck; Luigi Terracciano; Katharina M Fromm; Nina Khanna
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

3.  Excreted Cytoplasmic Proteins Contribute to Pathogenicity in Staphylococcus aureus.

Authors:  Patrick Ebner; Janina Rinker; Minh Thu Nguyen; Peter Popella; Mulugeta Nega; Arif Luqman; Birgit Schittek; Moreno Di Marco; Stefan Stevanovic; Friedrich Götz
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

4.  The νSaα Specific Lipoprotein Like Cluster (lpl) of S. aureus USA300 Contributes to Immune Stimulation and Invasion in Human Cells.

Authors:  Minh Thu Nguyen; Beatrice Kraft; Wenqi Yu; Dogan Doruk Demircioglu; Dogan Doruk Demicrioglu; Tobias Hertlein; Marc Burian; Mathias Schmaler; Klaus Boller; Isabelle Bekeredjian-Ding; Knut Ohlsen; Birgit Schittek; Friedrich Götz
Journal:  PLoS Pathog       Date:  2015-06-17       Impact factor: 6.823

5.  Impact of Insertion Sequences and Recombination on the Population Structure of Staphylococcus haemolyticus.

Authors:  Ons Bouchami; Herminia de Lencastre; Maria Miragaia
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

6.  Fluorescence characterization of clinically-important bacteria.

Authors:  Lewis R Dartnell; Tom A Roberts; Ginny Moore; John M Ward; Jan-Peter Muller
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

7.  Growth promotion of the opportunistic human pathogen, Staphylococcus lugdunensis, by heme, hemoglobin, and coculture with Staphylococcus aureus.

Authors:  Jeremy R Brozyna; Jessica R Sheldon; David E Heinrichs
Journal:  Microbiologyopen       Date:  2014-02-07       Impact factor: 3.139

8.  Hydrophobic interaction governs unspecific adhesion of staphylococci: a single cell force spectroscopy study.

Authors:  Nicolas Thewes; Peter Loskill; Philipp Jung; Henrik Peisker; Markus Bischoff; Mathias Herrmann; Karin Jacobs
Journal:  Beilstein J Nanotechnol       Date:  2014-09-10       Impact factor: 3.649

9.  Staphylococcus aureus Regulatory RNAs as Potential Biomarkers for Bloodstream Infections.

Authors:  Valérie Bordeau; Anne Cady; Matthieu Revest; Octavie Rostan; Mohamed Sassi; Pierre Tattevin; Pierre-Yves Donnio; Brice Felden
Journal:  Emerg Infect Dis       Date:  2016-09-15       Impact factor: 6.883

10.  Draft Genome Sequence of the Aureocin A53-Producing Strain Staphylococcus aureus A53.

Authors:  Olinda Cabral Silva Santos; Andreza Freitas Souza Duarte; Rodolpho Mattos Albano; Maria Carmo Freire Bastos
Journal:  Genome Announc       Date:  2016-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.